Nonalcoholic Steatohepatitis Clinical Trials
Nonalcoholic Steatohepatitis clinical trials test new medications, devices, and lifestyle interventions for nonalcoholic Steatohepatitis and related metabolic health. Corterve aggregates actively recruiting Nonalcoholic Steatohepatitis studies from ClinicalTrials.gov so you can browse them by location and eligibility. Many metabolic trials monitor weight, blood sugar, or cardiovascular markers over time. This page provides general information, not medical advice; consult your healthcare provider before joining a study.
Recruiting Nonalcoholic Steatohepatitis studies
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)NCT06318169PHASE389bio, Inc.Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With FibrosisBirmingham, Alabama
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHNCT06419374PHASE389bio, Inc.Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisBirmingham, Alabama
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHNCT06528314PHASE3Akero Therapeutics, IncNASH - Nonalcoholic SteatohepatitisBirmingham, Alabama
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in VeteransNCT05526144PHASE2VA Office of Research and DevelopmentNonalcoholic SteatohepatitisColumbia, Missouri
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceNCT05165706NAStanford UniversityDiabetes Mellitus, Type 2Stanford, California
- Investigating the Link Between Type 2 Immunity and NAFLD in Human ObesityNCT04232566Mayo ClinicObesity, MorbidScottsdale, Arizona
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)NCT04501406PHASE2University of FloridaType 2 Diabetes Mellitus (T2DM)Gainesville, Florida
- Non-Invasive Quantification of Liver Health in NASH (N-QUAN)NCT04054310NAPerspectumNASH - Nonalcoholic SteatohepatitisChandler, Arizona
- Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced FibrosisNCT05720663Virginia Commonwealth UniversityNonalcoholic SteatohepatitisRochester, Minnesota
- Evaluating the Pharmacokinetics and Safety of MiricorilantNCT07553663PHASE1Corcept TherapeuticsNonalcoholic Steatohepatitis (NASH)San Antonio, Texas
Nonalcoholic Steatohepatitis trials by state
Nonalcoholic Steatohepatitis trials by metro
Frequently asked questions
- How do I find recruiting Nonalcoholic Steatohepatitis clinical trials?
- Browse the actively recruiting Nonalcoholic Steatohepatitis studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Nonalcoholic Steatohepatitis clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Nonalcoholic Steatohepatitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.